CardioGenics Holdings

CGNH · OTC

$0.0001+$0.0001 (+0.00%)TodayMarket closed · Oct 6, 9:36 AM ET

No price history for this range.

About CGNH

CardioGenics Holdings, Inc. is a biotechnology company, which engages in the business of development and commercialization of diagnostic test products to the In Vitro Diagnostics testing market. The company is headquartered in Boca Raton, Florida. The company went IPO on 2004-06-09. The firm has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Employees: 4
Headquarters: Boca Raton, Florida
Listed: Jun 9, 2004
Sector: Health Care
Industry: Biotechnology
Website: cardiogenics.com

Leadership

CardioGenics Holdings executives
Name	Title	Since	Age
J.Neil Tabatznik	—	2009	66
Yahia Gawad	—	2009	58
James Essex	—	—	68
Linda Sterling	—	2009	55
Karim Murabet	—	—	58

Similar companies

Companies in the same industry as CardioGenics Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.